![](https://static.isu.pub/fe/default-story-images/news.jpg?width=720&quality=85%2C50)
2 minute read
2020 Financial Statements
from Gamma Gazette, Winter Edition No 33 by The Australian and New Zealand Society of Nuclear Medicine
by ANZSNM
2020 FINANCIAL STATEMENTS These statements were presented to members at the recent General Annual Meeting
STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME FOR THE Australian and New Zealand Society of Nuclear MedicineYEAR ENDED 31ST DECEMBER 2020 Limited ABN 35 133 630 029
STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME FOR THE YEAR ENDED 31ST DECEMBER, 2020
Note 2020 2019 $ $
REVENUE EXPENSES
Conference, meeting and committee expenses Journal expenses Research grant Management costs Administration & ARTnet expenses Depreciation expenses Website Development and maintenance costs Write off of equipment 2(a) 284,634 359,680
(131,364) (90,832) (13,267) (11,704) (19,454) (21,999) (152,325) (154,564) (41,618) (49,398) - (252) (6,276) (14,866) - (1,533)
Surplus/ (Loss) before income tax for the year Income tax expense Net profit / (loss) for the year Other comprehensive income Total other comprehensive income for the year Total comprehensive income for the year Total comprehensive income attributable to the members of the entity 3 (79,670) 14,532
(79,670) 14,532
(79,670) 14,532
(79,670) 14,532
2020 FINANCIAL STATEMENTS These statements were presented to members at the recent General Annual Meeting
STATEMENT OF FINANCIAL POSITION AS AT 31ST DECEMBER, 2020 Australian and New Zealand Society of Nuclear Medicine Limited ABN 35 133 630 029
STATEMENT OF FINANCIAL POSITION AS AT 31ST DECEMBER, 2020 Note 2020 2019 $ $
ASSETS
CURRENT ASSETS Cash and cash equivalents Trade and other receivables Other assets 4(a) 702,229 737,461 5 26,924 3,128 6 52,469 80,510
TOTAL CURRENT ASSETS
NON-CURRENT ASSETS Property, plant and equipment TOTAL NON-CURRENT ASSETS 781,622 821,099
7 - -
TOTAL ASSETS
781,622 821,099
LIABILITIES
CURRENT LIABILITIES Trade and other payables Revenue in advance
TOTAL CURRENT LIABILITIES
TOTAL LIABILITIES
NET ASSETS
8 91,064 85,817 2(b) 131,591 96,645 222,655 182,462 222,655 182,462 558,967 638,637
EQUITY
Retained earnings
TOTAL EQUITY
558,967 638,637 558,967 638,637
2020 FINANCIAL STATEMENTS These statements were presented to members at the recent General Annual Meeting
STATEMENT OF CHANGES IN EQUITY STATEMENT OF CHANGES IN EQUITY FOR THE YEAR ENDED 31ST DECEMBER, 2020
FOR THE YEAR ENDED 31ST DECEMBER, 2020
STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31ST DECEMBER 2020
Balance at 1 January, 2019
Profit attributable to the entity
Balance at 31st December, 2019
Profit attributable to the entity
Balance at 31st December, 2020 Retained Earnings Total
$ $ 624,105 624,105 14,532 14,532 638,637 638,637 (79,670) (79,670) 558,967 558,967
STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31ST DECEMBER 2020
CASH FLOW FROM OPERATING ACTIVITIES
Receipts from members & other operating activities Interest received Receipts on behalf of ARTnet Payments to suppliers and contractors Net cash provided by operating activities
CASH FLOW FROM INVESTING ACTIVITIES
Payment for property, plant and equipment Payment for intangible asset Net cash used in investing activities Net Increase in cash held Cash at the beginning of the financial year Cash at the end of the financial year
Note 2020 2019 $ $
193,646 369,324 3,074 3,799 - 50,000 (231,952) (338,308) 4(b) (35,232) 84,815
(35,232) 84,815 737,461 652,646 4(a) 702,229 737,461